Drug intelligence / Profile preview

Ergo Restore

Development stage: Unknown
Lead developer: Ergon Pharmaceuticals
Administration: Oral

Overview

**Ergo Restore** is a marketed oral Ayurvedic herbal medicine from Ergon Pharmaceuticals, supplied as a 500 mg capsule and identified by product listings as a Manmathavara Ras formulation. It is promoted for male sexual-health complaints, including reduced libido, erectile dysfunction, premature ejaculation, and perceived sexual weakness. Retailer material describes a multi-herb preparation containing ashwagandha, silk-cotton root, talmakhana, ghee, honey, and additional herbal and spice ingredients; however, the complete standardized composition and a specific molecular mechanism of action are not publicly stated. ([ergonbd.info](https://ergonbd.info/ergorestore.html))

Brand names: Ergo Restore
Other names: Manmathavara RasRestore 500Restore500Restore-500

Beyond the preview

Go deeper on Ergo Restore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ergo Restore.

Explore the full profile